Mattias Bodin

Mattias Bodin has an extensive work experience spanning over several companies and industries. Mattias started their career at IPC Pharma in 2008 as the General Manager, where they successfully established the Swedish subsidiary and made a significant impact on the medical devices market. In 2010, they joined Nortech Medical as the Managing Director and partner, leading the company's expansion and growth. In 2017, they became the Country Manager Sweden at Bluefish Pharmaceuticals, a generic company, before moving on to serve as a Board Member at Servicia Medical (Nordic Servicia Medical AB), a Medtech business. In 2018, they were appointed as the General Manager Nordic at Abcur / Advanz Pharma, where they were responsible for the Nordic market. In 2019, they co-founded Migränhjälpen, a digital caregiver company for patients with chronic migraine, and served as the Managing Director. Under their leadership, Migränhjälpen experienced rapid growth and became the largest clinic in Sweden helping patients with severe headache problems. In 2020, they joined LSI Alpha as a Member of the Investment Committee, followed by their role at LSI Gamma AB in 2022 in the same position. More recently, in 2023, they became a Member of the Investment Committee at Scale Up Life Science Invest. Throughout their career, Mattias Bodin has demonstrated their expertise in strategic management, business development, and leadership roles across various sectors.

Mattias Bodin began their education at Gymnasiet Vänersborg from 1983 to 1984. Following this, they attended Linköping University from 1987 to 1991, where they earned a Master's degree in Business, specifically, a Master (Civilekonom). In 1989 to 1990, they also studied at the University of Oklahoma in the field of Business. Additionally, in 1991, they attended LIF 1991 for Medicinsk grundutbildning, although the degree name for this program is not specified.